Identification of host dependency factors involved in SARS-CoV-2 replication organelle formation through proteomics and ultrastructural analysis.


Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
30 Nov 2023
Historique:
medline: 1 12 2023
pubmed: 31 10 2023
entrez: 31 10 2023
Statut: ppublish

Résumé

Remodeling of the cellular endomembrane system by viruses allows for efficient and coordinated replication of the viral genome in distinct subcellular compartments termed replication organelles. As a critical step in the viral life cycle, replication organelle formation is an attractive target for therapeutic intervention, but factors central to this process are only partially understood. In this study, we corroborate that two viral proteins, nsp3 and nsp4, are the major drivers of membrane remodeling in SARS-CoV-2 infection. We further report a number of host cell factors interacting with these viral proteins and supporting the viral replication cycle, some of them by contributing to the formation of the SARS-CoV-2 replication organelle.

Identifiants

pubmed: 37905840
doi: 10.1128/jvi.00878-23
pmc: PMC10688318
doi:

Substances chimiques

Viral Nonstructural Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0087823

Subventions

Organisme : Deutsche Forschungsgemeinschaft (DFG)
ID : 240245660-SFB1129, 272983813-TRR 179
Organisme : Helmholtz-Fonds (Helmholtz-Fonds e.V.)
ID : KA1-Co-02 'COVIPA'
Organisme : European Molecular Biology Organization (EMBO)
ID : ALTF 454-2020
Organisme : Free and Hanseatic City of Hamburg
Organisme : Deutsche Forschungsgemeinschaft (DFG)
ID : SC 314/1-1
Organisme : Bundesministerium für Bildung und Forschung (BMBF)
ID : VirMScan

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

PLoS Pathog. 2021 May 27;17(5):e1009599
pubmed: 34043740
Viruses. 2021 Oct 18;13(10):
pubmed: 34696522
J Biol Chem. 2010 Dec 24;285(52):40830-7
pubmed: 21030595
J Virol. 2004 Dec;78(24):13600-12
pubmed: 15564471
Nat Methods. 2019 Dec;16(12):1226-1232
pubmed: 31570887
Cell Rep. 2021 Nov 23;37(8):110049
pubmed: 34788596
Nat Rev Microbiol. 2019 Mar;17(3):181-192
pubmed: 30531947
Cell Death Dis. 2016 Nov 3;7(11):e2453
pubmed: 27809307
Science. 2020 Dec 4;370(6521):
pubmed: 33060197
Viruses. 2014 Jul 22;6(7):2826-57
pubmed: 25054883
J Virol. 2010 Jan;84(1):280-90
pubmed: 19846526
PLoS Genet. 2008 Jan;4(1):e21
pubmed: 18225958
Commun Biol. 2022 Jan 12;5(1):45
pubmed: 35022513
Cell. 2021 Jan 7;184(1):106-119.e14
pubmed: 33333024
Cell Host Microbe. 2021 Feb 10;29(2):267-280.e5
pubmed: 33357464
Mol Cell. 2021 Jul 1;81(13):2851-2867.e7
pubmed: 34118193
Nat Commun. 2020 Nov 18;11(1):5885
pubmed: 33208793
Proc Natl Acad Sci U S A. 2010 Oct 5;107(40):17345-50
pubmed: 20855599
Mol Cell. 2023 Jul 20;83(14):2559-2577.e8
pubmed: 37421942
PLoS Pathog. 2008 Jun 13;4(6):e1000088
pubmed: 18551169
Mol Syst Biol. 2015 Jan 21;11(1):775
pubmed: 25609649
Science. 2020 Sep 11;369(6509):1395-1398
pubmed: 32763915
Cell Host Microbe. 2020 Dec 9;28(6):853-866.e5
pubmed: 33245857
Nature. 2008 Jan 31;451(7178):587-90
pubmed: 18235502
Nat Methods. 2019 Jun;16(6):471-477
pubmed: 31086343
PLoS Biol. 2008 Sep 16;6(9):e226
pubmed: 18798692
Antiviral Res. 2016 Nov;135:97-107
pubmed: 27743916
NAR Cancer. 2021 Mar 22;3(1):zcab009
pubmed: 34316702
J Gen Virol. 2000 Apr;81(Pt 4):853-79
pubmed: 10725411
Cell Host Microbe. 2011 Jan 20;9(1):32-45
pubmed: 21238945
PLoS Pathog. 2016 Aug 10;12(8):e1005810
pubmed: 27509095
Autophagy. 2023 Feb;19(2):737-738
pubmed: 35900889
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
EMBO J. 2021 Aug 16;40(16):e107821
pubmed: 34159616
Trends Microbiol. 2020 Dec;28(12):1022-1033
pubmed: 32536523
Nature. 2022 Jun;606(7915):761-768
pubmed: 35551511
Cell Microbiol. 2021 Apr;23(4):e13302
pubmed: 33432690
mBio. 2013 Aug 13;4(4):
pubmed: 23943763
J Virol. 2004 Sep;78(18):9977-86
pubmed: 15331731
Cell Host Microbe. 2010 Jun 25;7(6):500-8
pubmed: 20542253
J Virol. 2021 Jan 28;95(4):
pubmed: 33257477
Cell. 2021 Jan 7;184(1):120-132.e14
pubmed: 33382968
J Virol. 2019 Aug 28;93(18):
pubmed: 31118263
Nat Commun. 2021 Dec 14;12(1):7276
pubmed: 34907161
J Cell Biol. 2023 Jul 3;222(7):
pubmed: 37093123
Nat Metab. 2022 Mar;4(3):310-319
pubmed: 35347318
Nat Protoc. 2007;2(8):1896-906
pubmed: 17703201
Mol Biol Cell. 2022 Aug 1;33(9):ar79
pubmed: 35609210
J Gen Virol. 2003 Sep;84(Pt 9):2305-2315
pubmed: 12917450
Nat Microbiol. 2019 Dec;4(12):2416-2429
pubmed: 31636417
Nucleic Acids Res. 2014 Dec 1;42(21):13150-60
pubmed: 25361978
Mol Cell Proteomics. 2021;20:100120
pubmed: 34186245
J Struct Biol. 2005 Oct;152(1):36-51
pubmed: 16182563
Nucleic Acids Res. 2019 Jan 8;47(D1):D607-D613
pubmed: 30476243
Nat Protoc. 2016 Dec;11(12):2301-2319
pubmed: 27809316
Mol Cell. 2021 Jul 1;81(13):2838-2850.e6
pubmed: 33989516
mBio. 2017 Nov 21;8(6):
pubmed: 29162711
Cell Rep. 2017 Feb 28;18(9):2113-2123
pubmed: 28249158
ACS Infect Dis. 2020 Dec 11;6(12):3174-3189
pubmed: 33263384
Nat Methods. 2016 Sep;13(9):731-40
pubmed: 27348712
Nat Rev Neurosci. 2021 Apr;22(4):209-222
pubmed: 33608673
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Nat Genet. 2022 Aug;54(8):1078-1089
pubmed: 35879412
J Struct Biol. 1996 Jan-Feb;116(1):71-6
pubmed: 8742726
PLoS Biol. 2020 Jun 8;18(6):e3000715
pubmed: 32511245
Antiviral Res. 2018 Jan;149:58-74
pubmed: 29128390

Auteurs

Felix Pahmeier (F)

Department of Infectious Diseases, Molecular Virology, Heidelberg University, Medical Faculty Heidelberg, Center for Integrative Infectious Disease Research , Heidelberg, Germany.

Teresa-Maria Lavacca (T-M)

Department of Infectious Diseases, Molecular Virology, Heidelberg University, Medical Faculty Heidelberg, Center for Integrative Infectious Disease Research , Heidelberg, Germany.

Sarah Goellner (S)

Department of Infectious Diseases, Molecular Virology, Heidelberg University, Medical Faculty Heidelberg, Center for Integrative Infectious Disease Research , Heidelberg, Germany.

Christopher J Neufeldt (CJ)

Department of Infectious Diseases, Molecular Virology, Heidelberg University, Medical Faculty Heidelberg, Center for Integrative Infectious Disease Research , Heidelberg, Germany.

Vibhu Prasad (V)

Department of Infectious Diseases, Molecular Virology, Heidelberg University, Medical Faculty Heidelberg, Center for Integrative Infectious Disease Research , Heidelberg, Germany.

Berati Cerikan (B)

Department of Infectious Diseases, Molecular Virology, Heidelberg University, Medical Faculty Heidelberg, Center for Integrative Infectious Disease Research , Heidelberg, Germany.

Sreejith Rajasekharan (S)

Systems Arbovirology, Leibniz Institute of Virology , Hamburg, Germany.

Giulia Mizzon (G)

Department of Infectious Diseases, Molecular Virology, Heidelberg University, Medical Faculty Heidelberg, Center for Integrative Infectious Disease Research , Heidelberg, Germany.
German Center for Infection Research, Heidelberg partner site , Heidelberg, Germany.

Uta Haselmann (U)

Department of Infectious Diseases, Molecular Virology, Heidelberg University, Medical Faculty Heidelberg, Center for Integrative Infectious Disease Research , Heidelberg, Germany.

Charlotta Funaya (C)

Electron Microscopy Core Facility, Heidelberg University , Heidelberg, Germany.

Pietro Scaturro (P)

Systems Arbovirology, Leibniz Institute of Virology , Hamburg, Germany.

Mirko Cortese (M)

Department of Infectious Diseases, Molecular Virology, Heidelberg University, Medical Faculty Heidelberg, Center for Integrative Infectious Disease Research , Heidelberg, Germany.

Ralf Bartenschlager (R)

Department of Infectious Diseases, Molecular Virology, Heidelberg University, Medical Faculty Heidelberg, Center for Integrative Infectious Disease Research , Heidelberg, Germany.
German Center for Infection Research, Heidelberg partner site , Heidelberg, Germany.
Division "Virus-Associated Carcinogenesis", German Cancer Research Center (DKFZ) , Heidelberg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH